Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

American Journal of Diseases of Children

Volumn 140, Issue 6, 1986, Pages 543-546

  Glezen, W Paul ^a   Taber, Larry H ^a   Frank, Arthur L ^a,b   Kasel, Julius A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

BRONCHIOLITIS; CASE REPORT; CROUP; DIAGNOSIS; HUMAN; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; RISK; TRACHEOBRONCHITIS;

CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFANT, NEWBORN; MALE; RECURRENCE; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS INFECTIONS; RISK; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022589125     PISSN: 0002922X     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.1986.02140200053026     Document Type: Article

References (19)

1. Chanock RM, Kim HW, Brandt CD, et al: Respiratory syncytial virus, in Evans AS (ed): Viral Infections of Humans, ed 2. New York, Plenum Publishing Corp, 1982, pp 471-489.
2. Hall CB, McBride JT, Walsh EE: Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med 1983;308: 1443-1447.
3. Taber LH, Knight V, Gilbert BE, et al: Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983;72: 613-618.
4. Dickens LE, Collins PL, Wertz GW: Transcriptional mapping of human respiratory syncytial virus. J Virol 1984;52: 364-369.
5. Walsh EE, Brandriss MW, Schlesinger JJ: Purification and characterization of respiratory syncytial virus fusion protein. J Gen Virol 1985; 66: 409-415.
6. Cote PJ Jr, Fernie BF, Ford EC, et al: Monoclonal antibodies to respiratory syncytial virus: Detection of virus neutralization and other antigen-antibody systems using infected human and murine cells. J Virol Methods 1981;3: 137-147.
7. Taber LH, Paredes A, Glezen WP, et al: Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg 1981;86: 303-313.
8. Gardner G, Frank AL, Taber L: Effects of social and family factors on viral respiratory infection and illness in the first year of life. J Epidemiol Community Health 1984;38: 42-48.
9. Glezen WP, Frank AL, Taber LH, et al: Parainfluenza virus type 3: Seasonality and risk of infection and reinfection in young children. J Infect Dis 1984;150: 851-857.
10. Henderson FW, Collier AM, Clyde WA Jr, et al: Respiratory-syncytial-virus infections, reinfections and immunity: A prospective, longitudinal study in young children. N Engl J Med 1979;300: 530-534.
11. Glezen WP, Six HR, Perrotta DM, et al: Epidemics and their causative viruses: Community experience, in Stuart-Harris CH, Potter CW (eds): The Molecular Virology and Epidemiology of Influenza. Orlando, Fla, Academic Press Inc, 1984, pp 17-32.
12. Glezen WP, Loda FA, Clyde WA Jr, et al: Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr 1971;78: 397-406.
13. Kim HW, Arrobio JD, Brandt CD, et al: Epidemiology of respiratory syncytial virus infection in Washington, DC: I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973;98: 216-225.
14. Glezen WP, Paredes A, Allison JE, et al: Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981;98: 708-715.
15. Glezen WP: Viral pneumonia as a cause and result of hospitalization. J Infect Dis 1983;147: 765-770.
16. Perrotta DM, Decker M, Glezen WP: Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985;122: 468-476.
17. New Vaccine Development: Establishing Priorities: I. Diseases of Importance in the United States. Washington, DC, National Academy Press, 1985.
18. Kim HW, Canchola JG, Brandt CD, et al: Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969;89: 422-434.
19. Hemming VG, Prince GA, Horswood RL, et al: Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis 1985;152: 1083-1087.